Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China flag China · Delayed Price · Currency is CNY
23.24
+0.29 (1.26%)
Apr 30, 2026, 3:00 PM CST

SHA:605033 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
911.95881.01694.02905.41841.93
Other Revenue
-4.525.010.630.56
911.95885.53699.03906.05842.49
Revenue Growth (YoY)
2.98%26.68%-22.85%7.54%48.19%
Cost of Revenue
599.62654.14478.04528.82532.38
Gross Profit
312.33231.39220.99377.23310.11
Selling, General & Admin
163.42141.19119.27153.18116.7
Research & Development
84.9374.3358.5380.0463.81
Other Operating Expenses
-0.812.232.753.452.9
Operating Expenses
247.55212.51178.09242.66187.05
Operating Income
64.7818.8842.9134.57123.06
Interest Expense
--0.01-0.38-0.98-3.31
Interest & Investment Income
6.329.336.586.862.61
Currency Exchange Gain (Loss)
-0.020-0.06
Other Non Operating Income (Expenses)
1.85-0.15-0.13-0.110.08
EBT Excluding Unusual Items
72.9528.0748.97140.34122.5
Gain (Loss) on Sale of Investments
0.870.47--0.07-
Gain (Loss) on Sale of Assets
--0.04-0.04-0.12-0.02
Asset Writedown
-21.4400.01--
Other Unusual Items
-9.3513.4712.2116.35
Pretax Income
52.3737.8662.41152.37138.83
Income Tax Expense
3.7114.857.2813.09
Net Income
48.6636.8657.56145.09125.74
Net Income to Common
48.6636.8657.56145.09125.74
Net Income Growth
32.03%-35.96%-60.33%15.38%59.70%
Shares Outstanding (Basic)
135137134136110
Shares Outstanding (Diluted)
135137134136110
Shares Change (YoY)
-0.98%1.99%-1.29%22.93%9.27%
EPS (Basic)
0.360.270.431.071.14
EPS (Diluted)
0.360.270.431.071.14
EPS Growth
33.33%-37.21%-59.81%-6.14%46.15%
Free Cash Flow
44.74121.59131.117.12-215.28
Free Cash Flow Per Share
0.330.890.980.13-1.95
Dividend Per Share
-0.1450.1500.2200.190
Dividend Growth
--3.33%-31.82%15.79%-
Gross Margin
34.25%26.13%31.61%41.63%36.81%
Operating Margin
7.10%2.13%6.14%14.85%14.61%
Profit Margin
5.34%4.16%8.23%16.01%14.92%
Free Cash Flow Margin
4.91%13.73%18.75%1.89%-25.55%
EBITDA
97.4339.3163.77150.05135.54
EBITDA Margin
10.68%4.44%9.12%16.56%16.09%
D&A For EBITDA
32.6420.4320.8715.4712.48
EBIT
64.7818.8842.9134.57123.06
EBIT Margin
7.10%2.13%6.14%14.85%14.61%
Effective Tax Rate
7.08%2.64%7.78%4.78%9.43%
Revenue as Reported
-885.53699.03906.05842.49
Advertising Expenses
-17.210.7827.3311.56
Source: S&P Global Market Intelligence. Standard template. Financial Sources.